Why the study?
As TAVR indications extend to younger and lower-risk patients, minimizing periprocedural complications and optimizing procedural results are crucial to achieve excellent long-term outcomes.
This review highlights that continuous refinement of TAVR devices and techniques will expand safety and eligibility, positioning TAVR as the likely first treatment option for patients needing a biological valve.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bruno et al. (2020) conducted a review in Aortic valve stenosis. Transcatheter aortic valve replacement (TAVR) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: